Discover 512 paid clinical trials in Iowa City, Iowa. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 512
University of Iowa Interventional Psychiatry Service Patient Registry
for
Treatment Resistant Depression, Major Depressive Episode,
Location: Iowa City IA
Sponsor: Mark Niciu
Sex: All
Age: 18 - 70+
Code: NCT04480918
Recruiting
Characterizing the Impact of Presbyphonia on Social Interaction
for
Presbyphonia
Location: Iowa City IA
Sponsor: Matthew R. Hoffman
Sex: All
Age: 65+
Code: NCT06441136
Recruiting
A Phase 1/2 Study of NRTX-1001 Neuronal Cell Therapy in Drug-Resistant Bilateral Mesial Temporal Lobe Epilepsy (MTLE)
for
Epilepsy, Temporal Lobe
Location: Iowa City IA, Chicago IL, Milwaukee WI, Little Rock AR,
Sponsor: Neurona Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT06422923
Phase1, Phase2, Recruiting
Evaluation of Pirfenidone as a Novel Therapeutic Strategy Against Recurrent Acute Pancreatitis.
for
Recurrent Acute Pancreatitis
Location: Iowa City IA, Rochester MN, Birmingham AL
Sponsor: University of Alabama at Birmingham
Sex: All
Age: 18 - 70+
Code: NCT06253117
Phase2, Recruiting
The Biomarkers in the Hyperbaric Oxygen Brain Injury Treatment Trial (BioHOBIT)
for
Traumatic Brain Injury
Location: Iowa City IA, Minneapolis MN, Detroit MI, Lexington KY,
Sponsor: University of Michigan
Sex: All
Age: 16 - 65
Code: NCT04855396
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of ASP1002 in Adults for Treatment of Solid Tumors
for
Advanced Solid Tumors
Location: Iowa City IA, Saint Paul MN, Louisville KY, Detroit MI,
Sponsor: Astellas Pharma Global Development, Inc.
Sex: All
Age: 18+
Code: NCT05719558
Phase1, Recruiting
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
for
Colorectal Neoplasms
Location: Iowa City IA, Peoria IL, Waukee IA, Madison WI,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06662786
Phase3, Recruiting
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)